Phase
Condition
Dyskinesias
Primary Immunodeficiency Disorders
Hiv Infections
Treatment
Unaffected Family Member Genetic Testing
Genetic Testing for PCD or PID
Clinical Study ID
Ages 5-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Pediatric subjects (aged 5-17 years): Inclusion criteria include the major criterion (bronchiectasis in > 1 lobe on current or chest CT in previous 24 months, if available for review), plus one minor criterion, or two minor criteria, if bronchiectasis is not present, (including at least 1 "lung" minor criteria).
Adult subjects (aged 18-45 years): Inclusion criteria include the major criteria (bronchiectasis in > 1 lobe on current or chest CT in previous 36 months, if available for review), plus one minor criterion, or three minor criteria, if bronchiectasis is not present, (including at least 1 "lung" minor criteria).
Inclusion Criteria:
General Criteria
Age 5-45 years
Male and Female Subjects
All races and ethnicities
Major Clinical Criteria
- Bronchiectasis in > 1 lobe
Minor Clinical Criteria, Lung
Neonatal respiratory distress (in term neonates with O2 requirement)
Chronic wet cough (year-round for at least 12 months)
Recurrent episodes of bacterial bronchitis
Recurrent pneumonia (confirmed on chest x-ray)
Respiratory non-tuberculous mycobacteria (NTM) (documented respiratory NTM culture)
Minor Clinical Criteria, Other
Chronic nasal congestion
Recurrent/chronic paranasal sinusitis
Ongoing middle-ear disease and/or tympanostomy tube placement at age ≥ 4 years
Organ laterality defect
Low nasal nitric oxide (< 77 nL/min) (by plateau measurement)
Confirmed family history of PID or PCD
Exclusion
Exclusion Criteria:
Anyone who has a confirmed genetic diagnosis of PCD or PID
Cystic Fibrosis
Alpha-antitrypsin deficiency in adults (18 years and older)
Congenital upper or lower airway anomalies
Post-lung or heart transplant, or other conditions requiring immunosuppressiontherapy
Other confounding features, such as lung disease due to prematurity (born < 28 weeksgestation) or HIV
Neurological compromise and evidence of recurrent aspiration
Conditions known to be commonly associated with bronchiectasis, such as priormycobacterium tuberculosis
Have not had standard clinical evaluation to address other potential causes ofchronic oto-sino- pulmonary disease, particularly cystic fibrosis, aspiration orairway anatomic abnormalities.
Study Design
Study Description
Connect with a study center
The Hospital for Sick Children
Toronto, Ontario M5G 0A4
CanadaActive - Recruiting
McGill University
Montréal, Quebec H4A 3J1
CanadaActive - Recruiting
Stanford University
Palo Alto, California 94304
United StatesActive - Recruiting
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesActive - Recruiting
National Heart, Lung and Blood Institute
Bethesda, Maryland 20814
United StatesActive - Recruiting
Washington University in St. Louis
Saint Louis, Missouri 63130
United StatesActive - Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27599
United StatesActive - Recruiting
Seattle Children's Hospital
Seattle, Washington 98105
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.